IN2012DN02000A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02000A IN2012DN02000A IN2000DEN2012A IN2012DN02000A IN 2012DN02000 A IN2012DN02000 A IN 2012DN02000A IN 2000DEN2012 A IN2000DEN2012 A IN 2000DEN2012A IN 2012DN02000 A IN2012DN02000 A IN 2012DN02000A
- Authority
- IN
- India
- Prior art keywords
- preparing
- salt
- formula
- intermediates useful
- provides processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24660809P | 2009-09-29 | 2009-09-29 | |
PCT/US2010/050481 WO2011041284A1 (en) | 2009-09-29 | 2010-09-28 | Process for preparing biphenyl imidazole compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN02000A true IN2012DN02000A (el) | 2015-07-24 |
Family
ID=43383440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2000DEN2012 IN2012DN02000A (el) | 2009-09-29 | 2010-09-28 |
Country Status (18)
Country | Link |
---|---|
US (4) | US8188294B2 (el) |
EP (1) | EP2483246B1 (el) |
JP (3) | JP5787893B2 (el) |
KR (1) | KR101750977B1 (el) |
CN (2) | CN105837511A (el) |
AU (1) | AU2010300788B2 (el) |
BR (1) | BR112012007145A8 (el) |
CA (1) | CA2771160A1 (el) |
ES (1) | ES2656820T3 (el) |
IL (1) | IL218003A (el) |
IN (1) | IN2012DN02000A (el) |
MX (1) | MX2012003616A (el) |
MY (1) | MY160382A (el) |
NZ (1) | NZ598278A (el) |
RU (1) | RU2552350C2 (el) |
TW (1) | TWI545114B (el) |
WO (1) | WO2011041284A1 (el) |
ZA (1) | ZA201202218B (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI448284B (zh) | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
RU2013126403A (ru) * | 2010-11-10 | 2014-12-20 | ТЕРЕВАНС БАЙОФАРМА Р энд Д ИП,ЛЛС | Кристаллические формы алкоксиимидазол-1-илметилбифенилкарбоновых кислот |
CN103664747A (zh) * | 2013-12-06 | 2014-03-26 | 刘雷芳 | 一种杂环联苯类化合物的制备方法 |
CN103664431B (zh) * | 2013-12-06 | 2016-11-16 | 德州学院 | 一种芳基-芳基联苯类化合物的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
CN1028755C (zh) * | 1991-01-04 | 1995-06-07 | 赫彻斯特股份公司 | 咪唑衍生物的制备方法 |
CA2058198A1 (en) | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
WO2005023758A2 (en) * | 2003-09-04 | 2005-03-17 | Bakulesh Mafatlal Khamar | Process for the preparation of losartan potassium form i |
KR101050256B1 (ko) * | 2005-08-31 | 2011-07-19 | 수벤 라이프 사이언시스 리미티드 | 로사르탄의 제조 방법 |
TWI448284B (zh) | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
TW201014830A (en) * | 2008-09-30 | 2010-04-16 | Theravance Inc | Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid |
WO2010045420A1 (en) | 2008-10-16 | 2010-04-22 | Theravance, Inc. | Methods for detecting sulfhydryl-containing compounds in a biological test sample |
-
2010
- 2010-09-21 TW TW099132085A patent/TWI545114B/zh not_active IP Right Cessation
- 2010-09-28 RU RU2012117812/04A patent/RU2552350C2/ru not_active IP Right Cessation
- 2010-09-28 MX MX2012003616A patent/MX2012003616A/es active IP Right Grant
- 2010-09-28 EP EP10763266.3A patent/EP2483246B1/en not_active Not-in-force
- 2010-09-28 KR KR1020127010980A patent/KR101750977B1/ko active IP Right Grant
- 2010-09-28 AU AU2010300788A patent/AU2010300788B2/en not_active Ceased
- 2010-09-28 BR BR112012007145A patent/BR112012007145A8/pt not_active IP Right Cessation
- 2010-09-28 MY MYPI2012000616A patent/MY160382A/en unknown
- 2010-09-28 JP JP2012531107A patent/JP5787893B2/ja not_active Expired - Fee Related
- 2010-09-28 WO PCT/US2010/050481 patent/WO2011041284A1/en active Application Filing
- 2010-09-28 CN CN201610182336.3A patent/CN105837511A/zh active Pending
- 2010-09-28 IN IN2000DEN2012 patent/IN2012DN02000A/en unknown
- 2010-09-28 CA CA2771160A patent/CA2771160A1/en not_active Abandoned
- 2010-09-28 US US12/891,964 patent/US8188294B2/en active Active
- 2010-09-28 CN CN2010800399736A patent/CN102482229A/zh active Pending
- 2010-09-28 NZ NZ598278A patent/NZ598278A/en not_active IP Right Cessation
- 2010-09-28 ES ES10763266.3T patent/ES2656820T3/es active Active
-
2012
- 2012-02-09 IL IL218003A patent/IL218003A/en not_active IP Right Cessation
- 2012-03-27 ZA ZA2012/02218A patent/ZA201202218B/en unknown
- 2012-04-25 US US13/455,339 patent/US8541597B2/en active Active
-
2013
- 2013-08-22 US US13/973,171 patent/US8889882B2/en not_active Expired - Fee Related
-
2014
- 2014-10-16 US US14/515,732 patent/US9221763B2/en not_active Expired - Fee Related
- 2014-11-27 JP JP2014239571A patent/JP2015044856A/ja active Pending
- 2014-11-27 JP JP2014239570A patent/JP2015042683A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN02751A (el) | ||
MX2012003343A (es) | Proceso para preparar compuestos azabiciclicos. | |
MY163187A (en) | Novel imidazo-oxazine compound or salt thereof | |
WO2011138281A3 (de) | Verfahren zur herstellung von dithiin-tetracarboxy-diimiden | |
MY164776A (en) | Heterocyclic compound | |
CL2011000936A1 (es) | Proceso de preparacion de compuestos derivados de l-alanina protegidos, utiles como intermediarios de la sintesis de compuestos moduladores opioides mu/delta. | |
MX2011007998A (es) | Nuevos herbicidas. | |
MY161132A (en) | Novel herbicides | |
UA102289C2 (ru) | Гербициды, полученные из циклопентадиона | |
MX2011007932A (es) | Herbicidas nuevos. | |
MY160392A (en) | Triptolide prodrugs | |
MY156954A (en) | PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSES | |
MX338514B (es) | Preparacion de intermediarios de posaconazol. | |
MX2009008660A (es) | Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos. | |
WO2008053334A3 (en) | An improved process for preparing rosuvastatin calcium | |
WO2011157390A3 (en) | Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds | |
MX2010004546A (es) | Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina. | |
MX2012006524A (es) | Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol. | |
HK1124842A1 (en) | Methods of preparing imidazole-based compounds | |
TN2011000355A1 (en) | Novel microbiocides | |
WO2012140490A3 (en) | Processes for preparing pitavastatin calcium | |
MX350430B (es) | Proceso para preparar compuestos acido 4-amino-5-bifenil-4-il-2-hi droximetil-2-metil-pentanoico. | |
IN2012DN02000A (el) | ||
WO2012063115A3 (en) | Process for the preparation of rosuvastatin calcium via novel amine intermediate | |
MX2012010443A (es) | Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos. |